Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Century Sage Scientific Holdings Limited

世 紀 睿 科 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1450)

GRANT OF SHARE OPTIONS

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited (''Listing Rules'').

The board (the ''Board'') of directors (the ''Directors'') of Century Sage Scientific Holdings Limited (the ''Company'', together with its subsidiaries, the ''Group'') announces that on 10 September 2020, share options (the ''Options'') in respect of up to 7,000,000 ordinary shares of HK$0.01 each in the share capital of the Company (the ''Shares'') were granted to eligible employees (the ''Grantees''), pursuant to the share option scheme adopted by the Company on 13 June 2014 (the ''Share Option Scheme''), subject to the acceptance by the Grantees. The following are the details of the Options granted:

Date of grant

Number of underlying Shares being the subject of the Options granted

  • 10 September 2020
  • in respect of 7,000,000 Shares

Exercise price per Share under the

:

HK$0.067

per

Share,

which

represents

the

Options

highest of

(i)

the closing price

per Share

of

HK$0.067

on the date of grant, i.e. 10

September 2020; (ii) the average closing price

of HK$0.0612 per Share as stated in the daily

quotation sheets issued by The Stock Exchange

of Hong Kong Limited for five business days

immediately preceding

the date

of grant;

and

  1. the nominal value of the Share, being HK$0.01

Closing price of the Shares on the

:

HK$0.067 per Share

date of grant

- 1 -

Exercise dates and validity period

:

The Options shall expire on the 10th anniversary

of the Options

date of adoption of the Share Option Scheme

(i.e. 13 June 2024), or the earlier termination of

the Options in accordance with the Share Option

Scheme. Among the Options, 4,000,000 of the

Options (''Director Options'') were granted to

Mr. Li Jinping, an executive Director, and shall

be exercisable from the 2nd anniversary of the

date of grant (i.e. 10 September 2022). The

remaining 3,000,000 of the Options shall be

exercisable from the 3rd anniversary of the date

of grant (i.e. 10 September 2023).

The above grant of the Director Options has been approved by the independent non- executive Directors and is not subject to approval by shareholders of the Company under Rule 17.04(1) of the Listing Rules.

Save as disclosed above, none of the Grantees is a Director, chief executive or substantial shareholder of the Company, nor any of their respective associates (as defined under the Listing Rules) of any of them.

By order of the Board

Century Sage Scientific Holdings Limited

Lo Chi Sum

Chairman

Hong Kong, 10 September 2020

As at the date of this announcement, the executive Directors are Mr. Lo Chi Sum, Mr. Leung Wing Fai, Mr. Geng Liang and Mr. Li Jinping, and the independent non-executive Directors are Mr. Hung Muk Ming, Dr. Ng Chi Yeung, Simon, and Mr. Mak Kwok Wing.

- 2 -

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Century Sage Scientific Holdings Ltd. published this content on 10 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 September 2020 11:04:02 UTC